Home > Offer to Sell > Intermediates > Pharmaceutical intermediates > Adenosine triphosphate disodium salt (ATP-2Na)
Adenosine triphosphate disodium salt (ATP-2Na)
Inquiry
| Post Date: | May 30,2016 |
| Expiry Date: | Aug 28,2016 |
| Detailed Description: |
Cas No. :51963-61-2
Specs:CP2005 Payment Method: TT in advance The purity of the product is not less than 98.0%. |
| CAS Registry Number: | 51963-61-2 |
| Synonyms: | ;5-ATP-Na2;Adenosine-5-triphosphate disodium salt hydrate;5Adenosinetriphosphoric acid disodium salt;ATP disodium salt;adenosine, 5'-(tetrahydrogen triphosphate), monosodium salt;adenosine, 5'-(tetrahydrogen triphosphate), sodium salt (1:2);Adenosine-5'-triphosphate,disodium salt;ATP,100mM Solution;Adenosine-5'-triphosphoric acid disodium salt;Adenosine-5'-triphosphate disodium salt;Adenosine-5'-triphosphate disodium salt;ATP-NA2;Adenosine Triphosphate Disodium;5'-Adenosine triphosphatedisodium salt;5'-ATP Na2;adenosine-5-triphosphate disodium sigma grade;adenosine disodium 5-triphosphate;9H-purin-6-amine, 9-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]pentofuranosyl]-, monosodium salt, monohydrate;Adenosine Triphosphate Disdium salt;ATP;Adenosine disodium triphosphate;Adenosine 5'-triphosphate disodium salt;Adenosine 5'-triphosphate disodium;5'-ATP*Na2; |
| Molecular Formula: | C10H14N5Na2O13P3 |
| Molecular Weight: | 551.1595 |
| Molecular Structure: | 
|
| Safety Description: | S22:; S24/25:; |
| Company: | Hangzhou Meiya Pharmaceutical Co.,Ltd [ China ] |
| Contact: | xie |
| Tel: | 0571-88091583 |
| Fax: | 0571-88091583 |
| Email: | meiya_pharm@163.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
